Programme

Aix Preliminary Programme 2010

3 Plenary (45 min)
10 Invited (30 min)
13 Oral communications selected from the abstracts. (20 min)
5 Technological communications (20 min)

5 Sessions
2 poster sessions will be organised:
Monday, 4 October, 2010
Themes:
Solid dosage forms (Buccal administration, Matrices/pellets, Tablets, Granulation) 48
Excipients 13
Biomaterials, bioengineering 10
Skin delivery 19
Hydrogels 7
Microparticles 11
Miscellaneous 8

Tuesday, 5 October, 2010
Themes:
Nanosystems: nanoparticles, micelles 53
Liposomes 20
Gene delivery 7
Emulsions 8
Ocular delivery 6
Prodrugs 8
Dissolution, bioavailability 21

(The number of posters in each session may change as we receive new abstracts each day)

Sunday, 3 October, 2010
14:00-18:00 Registration
18:00-19:00 Guided walk in Aix-en-Provence (included in the registration fee)
19:00-21:00 Welcome Reception at the City Hall ((included in the registration fee)
Monday, 4 October, 2010

08:00 – 09:00 Registration
Session 1.
Chairs: J .Siepmann/F. Alhaique

09:00 - 09:15 Welcome
09:15-10:00 Plenary Speaker 1. B. Cabane - Micelles, microemulsions and emulsions as drug
carriers: what are the boundaries according to thermodynamics?
10:00-10:30 Invited speaker 1. T. Rades - Modern spectroscopic techniques to characterise
pharmaceutical solids
10:30-10:50 Technical lecture 1. SPI-Pharma- C. Prost – Excipient system for making
durable tablets at low pressure
10:50-11:30 Coffee Break/Posters and Exhibition
11:30-11:50 Oral communication 1. 150 - L. A. Chiavacci - Controlled diclophenac delivery
from Ureasil-PEO-PPO hybrid matrix
11:50-12:10 Oral communication 2. 82 - P. Matricardi - Polysaccharidic hydrogels for
modified drug delivery
12:10-12:40 Invited speaker 2. J. Doucet - Novel opportunities offered by synchrotron light-
based techniques for the design and evaluation of drug delivery systems

12:40 -14:30 Lunch/Posters and Exhibition
Session 2
Chairs: M.T. Peracchia/A.R. Bilia

14:30-15:00 Invited speaker 3. S. Nicoli – Transscleral delivery of macromolecules: the
iontophoretic approach

15:00-15:20 Oral Communication 3. 75 - D. Pliszczak - Improvement of an encapsulation
process for the preparation of probiotics-loaded bioadhesive particles by using experimental
design

15:20-15:40 Oral Communication 4. 39 - J. Paulo Silva - Development of probiotic tablets:
viability studies

15:40-16:00 Oral Communication 5. 147 - S. Simovic - Enhancing the oral delivery of
lipophilic drugs using silica lipid hybrid (SLH) microcapsules
16:00-16:30 Coffee Break/Posters and Exhibition 16:30-16:50 Technical lecture 2. Ethypharm - G. Bastriat - Organogels, a new technology
for the drug sustained delivery

16:50-17:20 Invited Speaker 4. K. Maeder - Noninvasive monitoring of drug delivery by MRI,
ESR and Optical Imaging

Tuesday, 5 October, 2010
Session 3
Chairs: E. Fattal/P. Colombo

09:00-09:45 Plenary Speaker 2. C. Ventura - Hyaluronan Mixed Esters of Butyric and
Retinoic Acids: Differentiating and Paracrine Logics for Regenerative Medicine and
Cardiovascular Repair
09:45-10:15 Invited speaker 5. G. Ponchel - Characterization of molecular interactions as a
tool for designing multifunctional nanoparticles for targeting applications
10:15-10:35 Technical lecture 3. Capsugel - E. Jule - A systematic and rational approach to
lipid-based formulation development

10:35-11:05 Coffee Break/Posters and Exhibition
11:05-11:25 Oral communication 6. 65 - P. Lazzari - Non-ionic microemulsions containing
new diazabicyclo opioid compounds with improved antinociceptive activity
11:25-11:45 Oral communication 7. 86 - R. Cavalli - Dextran multilayer microbubbles as
ultrasound triggered doxorubicin carriers

11:45-12:05 Oral communication 8. 104 - P. Horcajada - Nanoparticles of porous iron
carboxylates as new drug carriers

12:05-12:35 Invited speaker 6. A.R. Bilia - NMR analysis of aggregates and supramolecular
complexes
12:35 -14:30 Lunch/Posters and Exhibition
Session 4
Chairs: A. Gazzaniga/G. Ponchel

14:30-15:00 Invited speaker 7. J. Irache - Poly(anhydride) nanoparticles for oral delivery of
poorly available drugs

15:00-15:20 Oral Communication 9. 238 - S. Mura - Toxicological effects of lung exposition
to biodegradable nanoparticles

15:20-15:40 Oral Communication 10. 127 - A. Müllertz - Characterization of precipitation
and redissolution of a poorly water-soluble drug fenofibrate in SMEDDS during in vitro
lipolysis

15:40-16:00 Oral Communication 11. 185 - O. Chambin - How the ionic strength of
dissolution media can control the release of a drug encapsulated in iota carrageenan
coatings

16:00-16:30 Coffee Break/Posters and Exhibition
16:30-16:50 Technical lecture 4. Gattefossé – V. Jannin – In vitro evaluation of
supersaturation drug delivery systems

16:50-17:20 Invited Speaker 8. M. Fresta - Targeted colloidal lipid-based drug carriers
20:15 - 23:30 Gala dinner (included in the registration fee)
Wednesday, 6 October, 2010

Session 5
Chairs: U. Conte/J. Irache

09:00-09:45 Plenary Speaker 3. V. P. Torchilin - Some novel approaches to the delivery of
DNA and siRNA

09:45-10:15 Invited speaker 9. M. Davies - Nanotechnology in drug delivery
10:15-10:35 Grants and poster awards
10:35-11:05 Coffee Break/Posters and Exhibition
11:05-11:25 Oral communication 12. 80 - M. Morpurgo – Evaluation of the in vivo fate and
targeting potentials of avidin-nucleic-acid nano-assemblies
11:25-11:45 Oral communication 13. 60 - M. Simon - Tumour targeting with a fusion toxin
derived from an EpCAM-specific designed ankyrin repeat protein using polymeric
Nanoparticles
11:45-12:15 Technical lecture 5. SOTAX - S. Haddouchi - Existing and new drug release
applications related to the USP Apparatus 4 (lecture to be confirmed)
12:15-12:45 Invited speaker 10. C. Valery - Peptide self-assembly and formulation:
the biomimetic approach

12:45 Concluding remarks

Source: http://www.apgi.org/documents/programmeaix.pdf